1. Long term HER2+ metastatic breast cancer survivors treated by trastuzumab: Results from the French cohort study LHORA
   J.-P. Spano et al, 2015, The Breast CrossRef
2. A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience
   Megan J. McKee et al, 2016, The Oncologist CrossRef
3. HER2-targeted therapy prolongs survival in patients with HER2-positive breast cancer and intracranial metastatic disease: a systematic review and meta-analysis
   Anders W Erickson et al, 2020, Neuro-Oncology Advances CrossRef
4. STATISTICAL ANALYSIS OF 100 BREAST CANCER CASES WITH EVALUATION OF HER2/NEU STATUS IMMUNOHISTOCHEMISTRY CORRELATION WITH GENE AMPLIFICATION BY FLUORESCENCE IN SITU HYBRIDIZATION ASSAY
   Sivakami Sivakami et al, 2018, Journal of Evolution of Medical and Dental Sciences CrossRef
5. Intracranial Metastatic Disease: Present Challenges, Future Opportunities
   Alyssa Y. Li et al, 2022, Frontiers in Oncology CrossRef
6. Combination of Radiotherapy and Targeted Agents in Brain Metastasis: An Update
   Zarmeneh Aly et al, 2016, Current Treatment Options in Neurology CrossRef
7. Systemic Therapy for HER2-Positive Central Nervous System Disease: Where We Are and Where Do We Go From Here?
   Eleonora Teplinsky et al, 2015, Current Oncology Reports CrossRef
8. Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts
   Masamichi Takahashi et al, 2019, Cancer Science CrossRef